Lynparza Receives FDA Approval With Abiraterone for Treatment of Specific Patients With Prostate Cancer
FDA Accepts New Drug Application for Tyrosine Kinase Inhibitor to Treat NSCLC Subset
Hair: A Bold, Bald Statement During Cancer
Conversations With Clinicians Make Way for MPN Symptom Control
